SHPA rejects vial sharing misinformation
SHPA has expressed concern following false and misleading comments regarding practices of vial sharing in health services and licenced compounding facilities providing chemotherapy published in PharmaDispatch yesterday.
SHPA President Professor Michael Dooley said hospitals and Therapeutic Goods Administration (TGA) licensed compounding facilities’ practices do not put patients at risk, and for people to indicate a risk exists is ill-informed and shows a distinct lack of understanding of the systems and processes in place to protect patients.
‘Hospitals and licensed compounding facilities operate under strict professional and regulatory standards which are all designed to ensure patient safety and the highest standards of patient care.
‘It is unfortunate that some individuals, without knowledge or experience of contemporary practice, have made incorrect statements that patient safety is at risk and that these statements may worry patients who are receiving treatment.
‘Patients can be assured that the medications they receive in hospitals that are prepared either within specialised aseptic pharmacy facilities in the hospital or are procured from licensed compounding facilities are of the highest quality,’ said Professor Dooley.
The availability and use of medicines in Australian hospitals is supported by rigorous governance frameworks and professional standards of practice and by the practice of individual pharmacists. This is reflected in the high-quality of medicines and services that Australian hospital patients receive.
Through its ongoing work with the federal government and jurisdictions, SHPA is ensuring that delivery of cancer treatments, including chemotherapy, to patients remains at the highest quality and is safe and accessible for all Australians.
‘All of our members but particularly those in SHPA’s Specialty Practice Oncology and Haematology network, are committed to delivering the best patient care at the bedside, and continually strive to optimise patient outcomes’ said Professor Dooley.
- 'SHPA defends pharmacists after vial sharing risk claims', AJP online, 10 August 2018
- 'SHPA blasts vial claim', Pharmacy Daily, 10 August 2018